Hem › Multipel skleros › Michigan
Kliniska studier för Multipel skleros i Michigan
10 studier för Multipel skleros söker deltagare vid platser i Michigan.
Städer i Michigan
Officiell studietext (engelska)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Northwest Neurology, Southfield
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06782490A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Ann Arbor
- TG Therapeutics Investigational Trial Site, Detroit
- TG Therapeutics Investigational Trial Site, Farmington
- och 2 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT06433752Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Michigan Institute for Neurological Disorders- Site Number : 8400004, Farmington Hills
RekryterarFas 3
Ålder 18 till 60 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07002034A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06680037Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
- Kahana Oculoplastic and Orbital Surgery, Livonia
RekryterarFas 3
Ålder 18 till 50 · Alla kön · Uppdaterad 14 aug. 2026 · NCT07623668A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Michigan Institute of Neurological, Farmington Hills
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 29 juli 2026 · NCT07225504Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
- University of Michigan, Ann Arbor
RekryterarFas 2
Ålder 18 till 65 · Alla kön · Uppdaterad 17 juli 2026 · NCT05269628A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
- Quest Research Institute, Farmington Hills
RekryterarFas 2
Ålder 18 till 55 · Alla kön · Uppdaterad 15 juni 2026 · NCT06735248Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
- Wayne State University, Detroit
RekryterarObservationsstudie
Ålder 18 till 60 · Alla kön · Uppdaterad 6 juni 2022 · NCT04458688Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.